Smith Group Asset Management’s bluebird bio BLUE Stock Holding History

Smith Group Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-172	Closed	-$350K	–	430
2018 Q2	$350K	Hold	172	–	–	0.01%	209
2018 Q1	$381K	Sell	172 -92	-35%	-$234K	0.01%	204
2017 Q4	$609K	Hold	264	–	–	0.02%	195
2017 Q3	$470K	Hold	264	–	–	0.02%	219
2017 Q2	$359K	Hold	264	–	–	0.01%	233
2017 Q1	$311K	Buy	+264	New	+$269K	0.01%	224

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smith Group Asset Management's BLUE Position: Q3 2018 in Review

Smith Group Asset Management sold out of bluebird bio (BLUE) in Q3 2018, closing a stake of 172 shares — an estimated $350K sold.

Smith Group Asset Management first reported a position in BLUE in Q1 2017 and held it in 6 quarters. The position peaked at $609K in Q4 2017. 288 funds tracked by Wall St. Rank hold BLUE as of Q3 2018.

Smith Group Asset Management reported no remaining bluebird bio position as of Q3 2018 after selling out during the quarter.
Smith Group Asset Management sold 172 bluebird bio shares in Q3 2018, an estimated $350K.
Smith Group Asset Management first reported a position in bluebird bio in Q1 2017 and held it in 6 quarters.
Smith Group Asset Management's bluebird bio position peaked at $609K in Q4 2017.
288 funds tracked by Wall St. Rank held bluebird bio as of Q3 2018.

Based on Smith Group Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.